158 results
8-K
EVOK
Evoke Pharma Inc
18 Mar 24
Other Events
5:02pm
Stockholders’ Equity Requirement; however, there can be no assurance that the Company will be in compliance with Minimum Stockholders’ Equity Requirement
424B3
EVOK
Evoke Pharma Inc
14 Mar 24
Prospectus supplement
6:44pm
be no assurance that we will be able to raise additional funds on acceptable terms, or at all. Because our business is entirely dependent on the success … our business. We cannot provide any assurance that our existing capital resources will be sufficient to enable us to continue the commercialization
8-K
a2duqxt058th 0hmuz9
23 Feb 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K
EX-1.1
n1s850
9 Feb 24
Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million
5:15pm
424B4
380pon
9 Feb 24
Prospectus supplement with pricing info
5:14pm
8-K
fdm df7s839h
29 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9:00am
8-K
9kjubp
22 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm